396 related articles for article (PubMed ID: 17257881)
1. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors.
Hisatomi M; Asaumi J; Yanagi Y; Unetsubo T; Maki Y; Murakami J; Matsuzaki H; Honda Y; Konouchi H
Oral Oncol; 2007 Oct; 43(9):940-7. PubMed ID: 17257881
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of dynamic contrast-enhanced MRI for submucosal palatal tumors.
Matsuzaki H; Yanagi Y; Hara M; Katase N; Hisatomi M; Unetsubo T; Konouchi H; Takenobu T; Nagatsuka H; Asaumi J
Eur J Radiol; 2012 Nov; 81(11):3306-12. PubMed ID: 22578835
[TBL] [Abstract][Full Text] [Related]
3. Minor salivary gland tumors in the oral cavity: diagnostic value of dynamic contrast-enhanced MRI.
Matsuzaki H; Yanagi Y; Hara M; Katase N; Asaumi J; Hisatomi M; Unetsubo T; Konouchi H; Takenobu T; Nagatsuka H
Eur J Radiol; 2012 Oct; 81(10):2684-91. PubMed ID: 22138118
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.
Yabuuchi H; Fukuya T; Tajima T; Hachitanda Y; Tomita K; Koga M
Radiology; 2003 Feb; 226(2):345-54. PubMed ID: 12563124
[TBL] [Abstract][Full Text] [Related]
5. The value of dynamic MRI studies in parotid tumors.
Alibek S; Zenk J; Bozzato A; Lell M; Grunewald M; Anders K; Rabe C; Iro H; Bautz W; Greess H
Acad Radiol; 2007 Jun; 14(6):701-10. PubMed ID: 17502260
[TBL] [Abstract][Full Text] [Related]
6. MR factor analysis: improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumors.
Eida S; Ohki M; Sumi M; Yamada T; Nakamura T
J Magn Reson Imaging; 2008 Jun; 27(6):1256-62. PubMed ID: 18504743
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
8. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
[TBL] [Abstract][Full Text] [Related]
9. [Salivary gland masses: dynamic MR imaging and pathologic correlation].
Park J; Inoue S; Ishizuka Y; Shindo H; Kawanishi M; Kakizaki D; Abe K; Ebihara Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Aug; 57(9):581-5. PubMed ID: 9293756
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland tumors at in vivo proton MR spectroscopy.
King AD; Yeung DK; Ahuja AT; Tse GM; Yuen HY; Wong KT; van Hasselt AC
Radiology; 2005 Nov; 237(2):563-9. PubMed ID: 16244265
[TBL] [Abstract][Full Text] [Related]
11. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.
Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T
Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183
[TBL] [Abstract][Full Text] [Related]
12. CT and MR images of pleomorphic adenoma in major and minor salivary glands.
Kakimoto N; Gamoh S; Tamaki J; Kishino M; Murakami S; Furukawa S
Eur J Radiol; 2009 Mar; 69(3):464-72. PubMed ID: 18093776
[TBL] [Abstract][Full Text] [Related]
13. [Value of manifestations of magnetic resonance imaging (MRI) in diagnosis of parotid tumors and their pathological bases].
Yuan JP; Liang BL; Xie BK; Song ZC; Zhong JL
Ai Zheng; 2003 May; 22(5):514-9. PubMed ID: 12753715
[TBL] [Abstract][Full Text] [Related]
14. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla.
Fruehwald-Pallamar J; Czerny C; Holzer-Fruehwald L; Nemec SF; Mueller-Mang C; Weber M; Mayerhoefer ME
NMR Biomed; 2013 Nov; 26(11):1372-9. PubMed ID: 23703801
[TBL] [Abstract][Full Text] [Related]
15. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
17. The value of dynamic contrast-enhanced MRI in diagnosis of malignant lymphoma of the head and neck.
Asaumi J; Yanagi Y; Hisatomi M; Matsuzaki H; Konouchi H; Kishi K
Eur J Radiol; 2003 Nov; 48(2):183-7. PubMed ID: 14680911
[TBL] [Abstract][Full Text] [Related]
18. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MRI for differentiation of major salivary glands neoplasms, a 3-T MRI study.
Aghaghazvini L; Salahshour F; Yazdani N; Sharifian H; Kooraki S; Pakravan M; Shakiba M
Dentomaxillofac Radiol; 2015; 44(2):20140166. PubMed ID: 25299931
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-Hodgkin lymphoma in oral and maxillofacial regions.
Matsuzaki H; Hara M; Yanagi Y; Asaumi J; Katase N; Unetsubo T; Hisatomi M; Konouchi H; Takenobu T; Nagatsuka H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jan; 113(1):126-33. PubMed ID: 22669071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
